
FCC router ban plugs into gains
Wall Street Breakfast
00:00
Outlook Therapeutics public offering drives drop
Julie Morgan explains OTLK's 25% premarket decline after announcing a best‑efforts public offering and warrants.
Play episode from 04:27
Transcript


